2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

Affiliations

• ¹ Department of Clinical Oncology, Zealand University Hospital Roskilde and Naestved, Roskilde; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
• ² Oncology Supportive Care Consultant, Overland Park, USA.
• ³ Department of Oncology, Odense University Hospital, Odense; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
• ⁴ College of Arts, Humanities and Education, University of Derby, Derby, UK.
• ⁵ Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.
• ⁶ The Medical Oncology Centre of Rosebank, Johannesburg; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
• ⁷ Genolier Cancer Center, Genolier, Switzerland.
• ⁸ Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, Canada.
• ⁹ Division of Hematology Oncology, Lahey Hospital and Medical Center, Burlington.
• ¹⁰ World Health Organization, Birmingham.
• ¹¹ William N. Pennington Cancer Institute, University of Nevada, Reno School of Medicine, Reno.
• ¹² Department of Neurosurgery, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham; Duke University School of Nursing, Duke University, Durham, USA.
• ¹³ Pharmacy Department, Clínica Universidad de Navarra, Madrid; School of Pharmacy and Nutrition, Universidad de Navarra, Pamplona, Spain.
• ¹⁴ Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California Irvine, Irvine, USA.
• ¹⁵ Independent Medical Oncologist, Milan, Italy.
• ¹⁶ Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
• ¹⁷ Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
• ¹⁸ Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, USA.
• ¹⁹ Medical Oncology Unit, Sant' Andrea Hospital of Rome, Rome, Italy.
• ²⁰ Clinic for Internal Medicine IV, Oncology - Hematology - Hemostaseology, University Hospital Halle (Saale), Halle, Germany.
• ²¹ Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
• ²² University of Perugia, Perugia, Italy.
• ²³ Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, India.
• ²⁴ Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan.
• ²⁵ Department of Pharmacy, OU Health Stephenson Cancer Center, Oklahoma City, USA.
• ²⁶ Department of Supportive Oncology and Palliative Care, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
• ²⁷ State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
• ²⁸ College of Nursing and Mo-Im Kim Nursing Research Institute, Yonsei University, Seoul, Korea.
• ²⁹ Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
• ³⁰ The Medical Oncology Centre of Rosebank, Johannesburg.
• ³¹ Department of Hematology, Oncology and Palliative Medicine, Ernst von Bergmann Hospital, Potsdam; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
• ³² ∗Interdisciplinary Patient Pathway Division, Gustave Roussy, Villejuif, France. Electronic address: [email protected].